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ABSTRACT The peroxidase and immunofluorescent. lo-
calization patterns of androgen-binding protein (ABP), a bio-
logical marker of Sertoli cell function, have been examined in
cultured Sertoli cells isolated from 20- to 22-day-old rats. ABP
immunoreactivity in the form of cytoplasmic granules of vari-
able diameter was observed in Sertoli cells with characteristic
lipid droplets and a colony-forming, epithelial-like growth
pattern. Incubation of cultures with [3H]thymidine demion-
strated that Sertoli cells continue to produce ABP while re-
taining their capability for synthesizing DNA and undergoing
mitosis. A variable number of cultured Sertoli cells became
morphologically transformed after exposure to follitropin (fol-
licle-stimulating hormone) and pharmacological agents acting
on cyclic nucleotide metabolism. The induced change in Sertoli
cell shape coincided with a disappearance of ABP-containing
granules from the cytoplasm. These observations demonstrate
that localization of ABP by immunological techniques is a
valuable tool for the characterization of structural and func-
tional properties of Sertoli cell in culture.
The Sertoli cell is a component of mammalian seminiferous
epithelia that synthesizes and secretes androgen-binding protein
(ABP) upon stimulation with follitropin (follicle-stimulating
hormone, FSH) and testosterone (1). FSH effects on the Sertoli
cell are mediated by increased production of cyclic AMP
(cAMP), which promotes physiological events through stimu-
lation of cAMP-dependent protein kinase activity (2, 3). After
release into the seminiferous tubular lumen, ABP. is transported
into the epididymis via testicular fluid and is concentrated in
caput epididymis (4). Although the physiological role of ABP
is not known, it has been suggested that this protein, with a high
binding affinity for 17j3-hydroxy-5a-androstan-3-one (5a-
dihydrotestosterone, 5a-DHT) and testosterone, provides an
adequate concentration of androgens for the normal function
of the androgen-dependent epididymis (5, 6).
Direct evidence for ABP secretion by Sertoli cells in the
presence of FSH, testosterone, and N6,O2'-dibutyryl cAMP
(Bt2cAMP) (7-9) comes from experiments using short-term
primary cultures of rat Sertoli cells. Thus, both the primary
Sertoli cell culture system and its biological marker, ABP, are
regarded as valuable tools for the assessment of Sertoli cell
physiological biochemical responses in vitro. However, until
recently it has not been certain whether Sertoli cells, assumed
to remain in a nondividing state in the adult testes (10), are
simply maintained in culture for short periods of time or pro-
liferate and reach confluency in dtro. It is of particular interest
to discriminate between these two possibilities because many
structural and functional properties of Sertoli cell cultures could
be evaluated not only in cultures with a limited life span but
also in cultures of prolonged viability and conserved cell-specific
functions.
Because ABP synthesis and secretion reflect a specific
functional status of Sertoli cells, efforts have been made in our
laboratories to purify ABP from rat epididymal cytosol and to
produce a specific ABP antiserum in order to use immunolog-
ical techniques for the study of ABP synthesis, secretion, and
uptake in vivo and in vitro.
In this paper, a specific antiserum against ABP has been used
to identify Sertoli cells in culture and to assess their secretory
and proliferative potential. We have used combined immu-
nocytochemical and autoradiographic procedures to examine
the potential of Sertoli cells in vitro for DNA synthesis and
mitosis. Our findings provide evidence that ABP-immuno-
reactive Sertoli cells isolated from 20- to 22-day-old rats can
synthesize DNA and undergo mitosis when explanted, cultured,
and subcultivated. In addition, we report results on the distri-
bution sites of ABP in morphologically transformed cells after
exposure to FSH, Bt2cAMP (a nonhydrolyzable derivative of
cAMP), 3-isobutyl-L-methylxanthine (MIX) (an inhibitor of
cyclic nucleotide phosphodiesterase which raises intracellular
concentration of cAMP), and a combination of FSH and
MIX.
METHODS
Isolation and Culture of Rat Sertoli Cells. Sertoli cells iso-
lated from testes of 20- to 22-day-old rats (Charles River CD)
were cultured by the method of Dorrington and Fritz (11),
slightly modified. Cells were cultured in Eagle's minimum
essential medium supplemented with 4 mM glutamine, sodium
pyruvate, 10% (vol/vol) fetal bovine serum, and antibiotics.
Aliquots of the resulting sample were seeded in tissue-culture
flasks and on glass coverslips kept in 60-mm plastic tissue-cul-
ture petri dishes.
ABP Purification and Characterization of Anti-ABP
Serum. ABP was purified from rat epididymis. A detailed de-
scription of ABP purification and characterization of anti-ABP
serum will be given elsewhere. Briefly, cytosol prepared from
350 g of caput epididymis and labeled with 5a-[1,2,4,5,6,7-
3H]DHT ([3H]DHT) was chromatographed on a DEAE-
Sepharose column and eluted on a Cl- gradient of 0.0-0.6 M.
Peak fractions were pooled, chromatographed on hydroxy-
apatite, and eluted in 5 mM KH2PO4/Na2HPO4 at pH 7.0.
Labeled fractions were applied to an affinity column of [3H]-
DHT-17I0-hemisuccinate coupled to Sepharose containing a
1,6-diaminohexand spacer (AH-Sepharose). ABP, eluted in 100
,uM 5a-DHT in 10% (wt/vol) dimethylformamide, was de-
salted on Sephadex G-25 and concentrated on a small DEAE-
Sepharose column. Final purification was by gel filtration
chromatography on Sephadex G-150. Purified ABP migrated
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as a single band corresponding to peak radioactivity on
steady-state polyacrylamide gel electrophoresis (12). The pu-
rified preparation also appeared homogeneous by equilibrium
centrifugation and had a Mr of 100,000. Electrophoresis on
NaDodSO4/polyacrylamide gels (13) yielded two bands with
Mr 45,000 and 41,000. The larger subunit was more abundant
than the smaller by about 3:1, as reported (14). Antibodies were
raised in rabbits and evaluated by inhibition of ABP binding
on steady-state polyacrylamide gel electrophoresis (15), by
crossimmunoelectrophoresis by the method of Laurell (16), and
by radioimmunoassay and immunocytochemistry as described
below.
ABP Radioimmunoassay. Purified ABP, labeled with '2'I
by the chloramine-T method (17) to specific activities up to 30
Ci/g (1 Ci = 3.7 X 1010 becquerels), was bound to the anti-ABP
serum (dilution 1:10,000) to a maximum of 40%. Identical
displacement curves were obtained with unlabeled purified
ABP (dose range, 0.2-200 ng) and with rat epididymal cytosol
(Fig. 1). This double-antibody radioimmunoassay system was
essentially as described (18).
ABP Immunocytochemistry. Sertoli cells grown on cover-
slips were fixed with 3.7% formaldehyde for 15 min and per-
meabilized with Triton X-100 (19). Immunocytochemical lo-
calization was carried out by two methods: indirect immu-
nofluorescence and peroxidase immunocytochemistry.
Indirect immunofluorescence. Anti-ABP serum generated
in rabbits was used as the primary immunoreagent. The anti-
serum (1:15, 1:20, and 1:45 dilutions) was applied directly to
the coverslips and allowed to incubate for 60 min in a moist
chamber at room temperature. To localize the bound ABP
antibody, we applied fluorescein isothiocyanate-conjugated
goat anti-rabbit IgG to the coverslips and allowed them to in-
cubate for an additional 30 min. After the coverslips were rinsed
in fresh phosphate-buffered saline, they were mounted on clean
microscope slides with a 50% (wt/vol) solution of glycerol in
phosphate-buffered saline. Preparations were examined with
a Leitz fluorescent microscope equipped with epi-illumina-
tion.
Peroxidase immunocytochemistry. After permeabilization,
the coverslips were stained by the unlabeled antibody-enyzme
bridge technique as described (20). Briefly, the coverslips were
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FIG. 1. Radioimmunoassay of rat ABP; overlapping standard
curves obtained with purified ABP (0) and rat epididymal cytosol
(REC) (0). B/Bo represents the fraction of the tracer bound to the
antibody in the presence of unlabeled ABP. Each point indicates the
mean value from triplicate determinations.
sequence: rabbit anti-ABP serum (working dilutions,
1:1000-1:10,000) for 1 hr; sheep anti-rabbit IgG serum (1:100)
for 10 min; rabbit anti-horseradish peroxidase serum (1:100)
for 10 min; horseradish peroxidase (5 ,g/ml) for 10 min; and
diaminobenzidine tetrahydrochloride (7.5 mg/ml) with 0.002%
H202 for 10 min. After a brief exposure to osmium vapor, the
cells were counterstained with toluidine blue, dehydrated,
cleared in xylene, and mounted with Permount (Fisher) on
clean microscope slides.
The specificity of immunocytochemical stainings for ABP
was assessed by the criteria described by Petrusz et al. (21).
Briefly, "method specificity" was tested by using increasing
dilutions of anti-ABP serum. In the peroxidase technique, no
staining was detectable at dilutions of 1:100,000 or higher. Thus,
positive staining depended on the primary antiserum only and
not on any of the subsequent staining reagents or on endogenous
peroxidase. "Antibody specificity" was evaluated by (i)
crossimmunoelectrophoresis; (ii) inhibition of ABP binding on
steady-state polyacrylamide gel electrophoresis; (iii) immu-
noperoxidase staining of rat testis and epididymis as well as of
other tissues with the same antiserum (22); and (iv) absorption
controls resulting in reduction of the staining intensity when
the anti-ABP serum was incubated with excess purified ABP
or with epididymal cytosol. Indirect immunofluorescent lo-
calization of ABP was used to compare distribution site and size
patterns of immunoreactive ABP with the peroxidase method.
The uniform nuclear fluorescent background observed in Sertoli
cell nuclei (Fig. 2d) probably represents nonspecific fluores-
cence resulting from natural antibodies present in the serum.
No fluorescence was observed after omission of the primary
antiserum.
Light Microscopic Autoradiography CQmbined with Im-
munocytochemistry. Sertoli cells were seeded on glass cover-
slips and cultured in 60-mm plastic culture dishes for 5-7 days
in Eagle's medium supplemented with fetal bovine serum. The
medium was discarded and replaced with fresh medium con-
taining [methyl-3H]thymidine (0.05 ,uCi/ml, specific activity
60 Ci/mmol; Schwarz/Mann). After a labeling time of 18 hr,
cells on coverslips were fixed in 3.7% (vol/vol) formaldehyde
in phosphate-buffered saline for 15-30 min and permeabilized
with 0.2% Triton X-100 for 2 min. Sertoli cells were then stained
for ABP by the indirect immunofluorescence or peroxidase
immunocytochemical procedure. After the immunocyto-
chemical staining step, coverslips were dried in air and
mounted, cell side upwards, on clean microscope slides with
Permount. The slides were dipped in Kodak NTB-3 Nuclear
Track emulsion, dried vertically, and stored in plastic slide boxes
containing Drierite. Autoradiograms were exposed at 4°C for
24-48 hr, developed in Kodak D-19 for 30 sec, rinsed in water,
and fixed for 5 min in Kodak Fixer.
Primary rat Sertoli cell cultures were dissociated with trypsin
after 5-7 days of culture in flasks and subcultured for 48 hr on
glass coverslips with Eagle's medium supplemented with fetal
bovine serum and 0.05 ,Ci of [3H]thymidine per ml. After 48
hr of continuous labeling, the medium was removed and re-
placed with fresh medium lacking [3H]thymidine and the cells
were cultured for an additional 48 hr. After a 1-hr incubation
in medium containing 50 ,ug of unlabeled thymidine per ml,
coverslips were processed for fluorescent and peroxidase im-
munocytochemistry combined with light microscopic autora-
diography.
To determine the specific incorporation of [3H]thymidine
into DNA and to remove soluble pools of the radioactively la-
beled precursor, we fixed Sertoli cells, growing on coverslips
in the presence of [3H]thymidine for 18-96 hr, in methanol/
acetic acid, 3:1 (vol/vol), and extracted the DNA with 5% tri-
chloroacetic acid. Coverslips were processed for light micro-
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5324 Cell Biology: Kierszenbaum et al.
scope autoradiography, omitting the immunocytochemical
staining for ABP. Results show that silver grains are concen-
trated exclusively on the nuclei of Sertoli cells that synthesize
DNA during the labeling period.
Hormonal and Pharmacological Treatments. Sertoli cells
were treated with FSH (NIAMDD ovine FSH-13) (1-5 Ag/ml)
or NIAMDD rat FSH B-1 (4 Ag/ml), MIX (0.5 mM), Bt2cAMP
(0.5 mM), and a mixture of FSH and MIX for 30,60,90, and
120 min. After treatments, Sertoli cells growing on coverslips
were processed for ABP immunocytochemistry. Ovine and rat
FSH were generously provided by the National Institute of
Arthritis, Metabolism and Digestive Diseases (NIAMDD) Rat
Pituitary Hormone Distribution Program and A. F. Parlow.
RESULTS
Peroxidase and Immunofluorescent Localization of ABP.
Sertoli cells prepared from 20- to 22-day-old rats and main-
tained in culture in the presence of fetal bovine serum or with
FSH in the absence of fetal bovine serum for 5 hr displayed
ABP immunoreactive granules of variable diameter in the
cytoplasm. Fig. 2a depicts a cluster of Sertoli cells with ABP in
close proximity to one or more cytoplasmic lipid-containing
droplets (as determined byPosmic acid saining). The formation,
distribution, and fate of lipid droplets within Sertoli cells in vio
and in vitro have been reported (23-25). Because of their as-
sociation with ABP-immunoreactive cells, both lipid droplets
and the epithelial-like, colony-forming growth pattern can be
regarded as valuable structural markers of Sertoli cells in cul-
ture. In general, ABP was randomly distributed throughout
Sertoli cell cytoplasm although smaller granules tended to ag-
gregate close to the nucleus (Fig. 2b). With the light microscope,
ABP was not detected in all Sertoli cells, especially in those
undergoing mitosis (Fig. 2c). Indirect immunofluorescent
studies of ABP yielded localization patterns (Fig. 2d) similar
to those seen in peroxidase-stained preparations.
[3H]Thymidine Uptake into ABP-Producing Sertoli Cells.
The finding of mitotic figures in Sertoli cell cultures was in-
yz 71W
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FIG. 3. Sertoli cells labeled with [3H]thymidine for 96 hr and
stained for ABP with peroxidase (a) and immunofluorescent (b)
stainings. Combined immunocytochemistry-autoradiographic pro-
cedures were used. (a) Silver grains are seen over the nuclei. ABP
peroxidase-stained granules are slightly faded out by the photographic
emulsion. (X1500.) (b) ABP immunofluorescent granules are depicted
in the cytoplasm of a Sertoli cell-with extensive [3H]thymidine la-
beling. (Inset) The same cell observed with transmitted illumination
and showing the silver grains. (X1200.)
terpreted as indicating a proliferative potential of Sertoli cells
in -culture. Two different experiments were carried out to de-
termine whether proliferating cells were indeed Sertoli cells
retaining ABP-producing capability or proliferative non-Sertoli
cell contaminants (i.e., fibroblasts) that might be present in
primary cultures. In one experiment, primary Sertoli cell cul-
tures on coverslips growing in a subconfluent monolayer were
labeled with [3H]thymidine for 18 hr, stained for ABP (perox-
idase or immunofluorescence), and processed for autoradi-
ography. A quantitative analysis of the autoradiograms dem-
onstrated that 17-20% of Sertoli cells were labeled with [3H]-
thymidine and ABP could be detected in approximately 30-
35% of the [3H]thymidine-labeled cells In another experiment,
primary Sertoli cell cultures were detached from the substrate
with trypsin, seeded on coverslips (2 X 103 cells per coverslip),
continuously labeled with [3H]thymidine for 48 hr immediately
after seeding, and prepared for immunocytochemistry and
.I





FIG. 2. Immunocytochemical localization of ABP in primary cultures of Sertoli cells obtained from 22-day-old rats. Cells were cultured
in Eagle's medium supplemented with 10% fetal bovine serum. (a) Colony-forming Sertoli cells containing one or more lipid droplets display
extensive cytoplasmic ABP immunoreactivity. (X700.) (b) ABP granules of variable size are randomly distributed throughout the cytoplasm.
ABP-immunoreactive granules tend to cluster in a juxtanuclear region opposite the lipid droplet. (X1900.) (c) ABP-immunoreactive Sertoli
cell and a mitotic (anaphase) Sertoli cell lacking ABP immunoreactivity coexist in the same field. (X1700.) (d) Immunofluorescent ABP granules
are similar in size and cell distribution to those depicted in immunoperoxidase-stained Sertoli cells. (X1700.) (a-c, Immunoperoxidase staining;
d, impaunofluorescent staining.)
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FIG. 4. Effect ofFSH, MIX, and FSH plus MIX on Sertoli cell shape and ABP distribution. Prior to the treatments, Sertoli cells were kept
in Eagle's medium without serum for 24 hr. (a) FSH, 60 min; ABP-immunoreactive cells morphologically changed and unchanged coexist in
the same field. (X700.) (b) MIX, 60 min; a higher proportion of Sertoli cells modify their cell shape and decrease their ABP content. (X700.)
(c) FSH plus MIX, 120 min; ABP displays a preferential localization along the cytoplasmic processes of morphologically transforming Sertoli
cells. (X1600.)
autoradiography 48 hr later. After 96 hr. the number of Sertoli
cells per coverslip was 6 X 103. Autoradiograms showed that
90-95% of Sertoli cells were associated with silver grains over
the nuclei and 30% of the [3H]thymidine-labeled cells showed
ABP cytoplasmic localization sites (Fig. 3). Because cells in these
preparations lacking ABP immunoreactivity still displayed lipid
droplets and an epithelial-like growth pattern, we assumed that
these apparently inactive ABP-producing cells (at the light
microscopic resolution level) were indeed Sertoli cells.
Hormonal and Pharmacological Responsiveness of ABP-
Producing Sertoli Cells. Several laboratories have reported that
cultured rat Sertoli cells exposed to FSH or Bt2cAMP for 24 hr
or more change their characteristic flat, epithelial-like cell shape
into a stellate or spindle-like shape (26-28). To further establish
a possible relationship between ABP localization and the early
occurrence of hormonally and pharmacologically induced
changes in Sertoli cell shape (within 30-120 min), we stimulated
Sertoli cells grown on coverslips to a subconfluent monolayer
with FSH, MIX, Bt2cAMP, and a combination of FSH and MIX.
Addition of FSH, MIX, and Bt2cAMP to the medium induced
striking changes in the shape of Sertoli cells. During 60 min, a
considerable number of Sertoli cells acquired the typical
elongated, often stellate, cell shape whereas other cells remained
morphologically unchanged. Because it may be argued that the
stellate responsive cells are Sertoli cells whereas nonresponsive
cells represent cell contaminants, we used the immunocyto-
chemical approach to establish the identity of responsive and
nonresponsive cells. Fig. 4a shows that ABP was observed in the
cytoplasm of FSH-treated Sertoli cells (60 min) undergoing
changes in cell shape as well as -in Sertoli cells with conserved
shape. Treatment with MIX for a similar period of time resulted
in a considerable number of cells converted to elongated-stellate
forms (Fig. 4b). ABP immunoreactivity decreased in the
morphologically transformed cells but was present in Sertoli
cells showing intermediate shape changes. Treatment with FSH
plus MIX for 120 min induced similar changes in cell shape. Fig.
4c shows the localization of ABP along Sertoli cell cytoplasmic
processes. Time-lapse photography (not shown) has been done
to follow the temporal sequence of cellular changes in indi-
vidual Sertoli cells after various hormonal and pharmacological
treatments. Results of those studies are consistent with the above
observations.
DISCUSSION
The immunocytochemical and autoradiographic results pre-
sented in this paper represent a step toward the structural and
functional characterization of Sertoli cells in culture by using
ABP as a biological marker. ABP antiserum provides a useful
tool for monitoring the critical mass of ABP-producing Sertoli
cells in tissue-culture preparations in relation to their prolifer-
ation rates and hormone responsiveness. Data presented here
demonstrate that, despite the negligible potential for postpu-
beral DNA synthesis in vivo (10, 29), Sertoli cells in vitro can
undergo DNA synthesis and mitosis while maintaining their
capacity to produce ABP.
Sertoli cells in the seminiferous epithelium of newborn rats
increase in number by an accelerated mitotic rate which greatly
decreases soon after the animals are 21 days old coincident with
the establishment of the meiotic process. After puberty, Sertoli
cells constitute a unique stable cell population in the seminif-
erous epithelium. Sertoli cells remain in constant interphase
whereas spermatogonia, spermatocytes, and spermatids are
involved in mitotic, meiotic, and cell differentiation processes,
respectively. Among the various functions attributed to Sertoli
cells (30), it is believed that these cells provide mechanical
support for germinal cells and play an important role in the
transfer of nutrients and metabolites between the intertubular
space and the lumen of the tubules (31). In addition to the
transport of nutrients and metabolites, it has been assumed that
some kind of regulation may be mediated through a cyclic
physiological function of Sertoli cells during spermatogenesis
and spermiogenesis (32).
Several laboratories have studied DNA synthesis and cell
division of Sertoli cells in primary cultures established from 20-
to 22-day-old rats, an age at which Sertoli cell proliferation rate
declines in vivo (29). These studies have reported significant
(33), low (25), or absent (29) DNA synthesis and mitosis.
Griswold et al. (33) have shown that FSH or Bt2cAMP added
to Eagle's medium lacking serum stimulates the incorporation
of [3H]thymidine into nuclear DNA, as detected by autoradi-
ography. Stimulation of DNA synthesis was detected 24 hr after
treatment with FSH or Bt2cAMP, reaching a maximum 72-96
hr after the treatments. By using both pulse and continuous
[3H]thymidine labeling, these authors reported that DNA
synthesis takes place in no more than 20% of Sertoli cells cul-
tured in the presence of FSH and Bt2cAMP. Cell counts in our
autoradiograms demonstrate that after 96 hr of [3H]thymidine
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labeling, silver grains are detected on nuclei of 90-95% of
subcultured Sertoli cells growing in Eagle's medium supple-
mented with fetal bovine serum. ABP immunoreactivity is
observed in approximately 30% of the cells labeled with [3H]-
thymidine. This apparent discrepancy may be attributed to
differences in the composition of tissue culture media or in the
cellular population density at the time of labeling. Further
studies are required to monitor the growth behavior of Sertoli
cells isolated from animals of various ages in a more "defined"
medium. In this respect, Mather and Sato (34) have recently
reported that Sertoli cells plated directly into serum-free
F12/Dulbecco's modified Eagle's medium supplemented with
hormones and growth factors could be subcultured and kept
viable for more than 1 month. These Sertoli cells were not tested
for maintenance of ABP production.
Because most of the mitotic and DNA synthetic activities are
significantly lower in Sertoli cells of 20-day-old rats in vivo (10),
a basic question arises concerning the possible reprogramming
of Sertoli cells in vitro, resulting in the expression of fetal and
early postnatal characteristics of DNA synthesis and cell divi-
sion. The reprogramming may be explained in terms of a
dedifferentiation process or a cessation of negative feedback
signals originating in the testis or extratesticularly.
Although the present work provides evidence that Sertoli cells
can be subcultured without any significant loss of ABP synthesis
compared to primary cultures, we found that only 30% of
[3H]thymidine-labeled Sertoli cells contained detectable
amounts of ABP. This result suggests that a large percentage
of cultured Sertoli cells do not produce ABP. Because Sertoli
cells in culture maintain nonsynchronous growth, it may be
assumed that they are in different stages of the cell cycle. One
possible explanation for the lack of ABP immunoreactivity in
some cells is that the ABP gene is not expressed throughout the
cell cycle; however, all of the ABP-containing cells may not
have been detected in this study. Electron microscopic im-
munocytochemical procedures may facilitate the identification
of ABP-containing granules with sizes below the resolution limit
of the light microscope and, therefore, determine the existence
of a higher percentage of ABP-producing cells. High-resolution
immunocytochemistry combined with the use of a more de-
fined medium and synchronized Sertoli cell populations will
be necessary approaches to define optimal conditions for ABP
synthesis and secretion.
This study and studies in other laboratories (26-28) have
shown that Sertoli cells in vitro exposed to FSH, MIX, and
Bt2cAMP show morphological changes in a variable proportion
of cells. ABP tends to localize along cytoplasmic cell processes
of stellate cells and eventually disappears from transformed
Sertoli cells as a function of time. Because ABP immunocyto-
chemistry provides an unambiguous basis for distinguishing
between morphologically changed and unchanged Sertoli cells,
the variation in the rates of changes of cell shape cannot be at-
tributed to nonresponsive cell contaminants. Variation in the
conversion rate of Sertoli cells from an epithelial-like to a stellate
shape could depend on the phase of the cell cycle, the time
course of the exposure to the biological agent, the degree of cell
confluency at the time when a biological agent is added, the
chemical nature and concentration of the biological agent, and
the physical and chemical nature of the culture substrate. The
first mechanism is consistent with experiments in which in-
duction of morphological changes in cultured Chinese hamster
ovary (CHO) cells by MIX was found to be dependent on the
phase of the cell cycle (35). Morphological flat-stellate transition
of CHO cells induced by the presence of MIX in the medium
was initiated only in G1 cells but persisted through following
cell cycle phases as long as MIX was maintained in the medium.
The relative contributions of these mechanisms to Sertoli cell
responsiveness should greatly enhance our understanding of
the precise sequence of physiological events involved in ABP
synthesis and secretion.
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